The mitogen-inducible Fn14 gene encodes a type I transmembrane protein that modulates fibroblast adhesion and migration
- PMID: 10551889
- DOI: 10.1074/jbc.274.46.33166
The mitogen-inducible Fn14 gene encodes a type I transmembrane protein that modulates fibroblast adhesion and migration
Abstract
The binding of polypeptide growth factors to their appropriate cell surface transmembrane receptors triggers numerous biochemical responses, including the transcriptional activation of specific genes. We have used a differential display approach to identify fibroblast growth factor-1-inducible genes in murine NIH 3T3 cells. Here, we report that the fibroblast growth factor-inducible-14 (Fn14) gene is a growth factor-regulated, immediate-early response gene expressed in a developmental stage- and adult tissue-specific manner in vivo. This gene, located on mouse chromosome 17, is predicted to encode an 129-amino acid type Ia membrane protein with no significant sequence similarity to any known protein. We have used two experimental approaches, direct fluorescence microscopy and immunoprecipitation analysis of biotinylated cell surface proteins, to demonstrate that Fn14 is located on the plasma membrane. To examine the biological consequences of constitutive Fn14 expression, we isolated NIH 3T3 cell lines expressing variable levels of epitope-tagged Fn14 and analyzed their phenotypic properties in vitro. These experiments revealed that Fn14 expression decreased cellular adhesion to the extracellular matrix proteins fibronectin and vitronectin and also reduced serum-stimulated cell growth and migration. These results indicate that Fn14 is a novel plasma membrane-spanning molecule that may play a role in cell-matrix interactions.
Similar articles
-
The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas.Am J Pathol. 2000 Apr;156(4):1253-61. doi: 10.1016/S0002-9440(10)64996-6. Am J Pathol. 2000. PMID: 10751351 Free PMC article.
-
The Fn14 cytoplasmic tail binds tumour-necrosis-factor-receptor-associated factors 1, 2, 3 and 5 and mediates nuclear factor-kappaB activation.Biochem J. 2003 Apr 15;371(Pt 2):395-403. doi: 10.1042/BJ20021730. Biochem J. 2003. PMID: 12529173 Free PMC article.
-
TWEAK is an endothelial cell growth and chemotactic factor that also potentiates FGF-2 and VEGF-A mitogenic activity.Arterioscler Thromb Vasc Biol. 2003 Apr 1;23(4):594-600. doi: 10.1161/01.ATV.0000062883.93715.37. Epub 2003 Feb 20. Arterioscler Thromb Vasc Biol. 2003. PMID: 12615668
-
Tumor Necrosis Factor Receptor Mediates Fibroblast Growth Factor-Inducible 14 Signaling.Cell Physiol Biochem. 2017;43(2):579-588. doi: 10.1159/000480530. Epub 2017 Sep 21. Cell Physiol Biochem. 2017. PMID: 28934756 Review.
-
TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor.Cytokine Growth Factor Rev. 2003 Jun-Aug;14(3-4):241-9. doi: 10.1016/s1359-6101(03)00019-4. Cytokine Growth Factor Rev. 2003. PMID: 12787562 Review.
Cited by
-
Proteolytically generated soluble Tweak Receptor Fn14 is a blood biomarker for γ-secretase activity.EMBO Mol Med. 2022 Oct 10;14(10):e16084. doi: 10.15252/emmm.202216084. Epub 2022 Sep 7. EMBO Mol Med. 2022. PMID: 36069059 Free PMC article.
-
Mechanisms of drugs-resistance in small cell lung cancer: DNA-related, RNA-related, apoptosis-related, drug accumulation and metabolism procedure.Transl Lung Cancer Res. 2020 Jun;9(3):768-786. doi: 10.21037/tlcr-19-547. Transl Lung Cancer Res. 2020. PMID: 32676338 Free PMC article. Review.
-
TWEAK induces liver progenitor cell proliferation.J Clin Invest. 2005 Sep;115(9):2330-40. doi: 10.1172/JCI23486. Epub 2005 Aug 18. J Clin Invest. 2005. PMID: 16110324 Free PMC article.
-
TWEAK binding to the Fn14 cysteine-rich domain depends on charged residues located in both the A1 and D2 modules.Biochem J. 2006 Jul 15;397(2):297-304. doi: 10.1042/BJ20051362. Biochem J. 2006. PMID: 16526941 Free PMC article.
-
TWEAK/Fn14 Signaling Axis Mediates Skeletal Muscle Atrophy and Metabolic Dysfunction.Front Immunol. 2014 Jan 27;5:18. doi: 10.3389/fimmu.2014.00018. eCollection 2014. Front Immunol. 2014. PMID: 24478779 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases